Ignite Creation Date:
2025-12-24 @ 10:44 PM
Ignite Modification Date:
2025-12-25 @ 8:14 PM
Study NCT ID:
NCT03545035
Status:
COMPLETED
Last Update Posted:
2022-05-12
First Post:
2018-05-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Efficacy and Safety in Patients With Chronic Lymphocytic Leukemia (CLL) Treated With Idelalisib and Rituximab in the Clinical Practice: a GIMEMA-ERIC Study
Sponsor:
Gruppo Italiano Malattie EMatologiche dell'Adulto
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-02-06
Start Date Type:
ACTUAL
Primary Completion Date:
2020-10-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-10-28
Completion Date Type:
ACTUAL
First Submit Date:
2018-05-22
First Submit QC Date:
None
Study First Post Date:
2018-06-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-05-11
Last Update Post Date:
2022-05-12
Last Update Post Date Type:
ACTUAL